Biomarkers for Risk Stratification in Lung Cancer
Biomarkers for Risk Stratification in Lung Cancer
Recruiting · NCT03774758 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers for Risk Stratification in Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-06-04 | NCT03774758 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Guardant Health, Inc. | 14 |
| Northern California Institute of Research and Education | 12 |
| University of California, San Francisco | 637 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| San Francisco VA Medical Center | San Francisco | United States | 12 |
| University of California, San Francisco | San Francisco | United States | 8 |
| Zuckerberg San Francisco General Hospital and Trauma Center | San Francisco | United States | 10 |